These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 6345111
1. Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis. Graham DY, Patterson DJ. Dig Dis Sci; 1983 Jun; 28(6):559-63. PubMed ID: 6345111 [Abstract] [Full Text] [Related]
2. Antacids and cimetidine treatment for gastro-oesophageal reflux and peptic oesophagitis. Cucchiara S, Staiano A, Romaniello G, Capobianco S, Auricchio S. Arch Dis Child; 1984 Sep; 59(9):842-7. PubMed ID: 6385868 [Abstract] [Full Text] [Related]
3. Sucralfate and alginate/antacid in reflux esophagitis. Laitinen S, Ståhlberg M, Kairaluoma MI, Kiviniemi H, Pääkkönen M, Lahtinen J, Poikolainen E, Aukee S. Scand J Gastroenterol; 1985 Mar; 20(2):229-32. PubMed ID: 2986275 [Abstract] [Full Text] [Related]
4. Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study. Petrokubi RJ, Jeffries GH. Gastroenterology; 1979 Oct; 77(4 Pt 1):691-5. PubMed ID: 381093 [Abstract] [Full Text] [Related]
5. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China. Sun J, Yang C, Zhao H, Zheng P, Wilkinson J, Ng B, Yuan Y. Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097 [Abstract] [Full Text] [Related]
7. Why do apparently healthy people use antacid tablets? Graham DY, Smith JL, Patterson DJ. Am J Gastroenterol; 1983 May; 78(5):257-60. PubMed ID: 6846300 [Abstract] [Full Text] [Related]
8. Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial. Grove O, Bekker C, Jeppe-Hansen MG, Karstoft E, Sanchez G, Axelsson CK, Nielsen HO, Andersen B, Rask-Madsen J. Scand J Gastroenterol; 1985 May; 20(4):457-61. PubMed ID: 3895381 [Abstract] [Full Text] [Related]
10. Sucralfate versus alginate/antacid in the treatment of peptic esophagitis. Evreux M. Am J Med; 1987 Sep 28; 83(3B):48-50. PubMed ID: 2821808 [Abstract] [Full Text] [Related]
12. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease. Thomas E, Wade A, Crawford G, Jenner B, Levinson N, Wilkinson J. Aliment Pharmacol Ther; 2014 Mar 28; 39(6):595-602. PubMed ID: 24471505 [Abstract] [Full Text] [Related]
17. Double-blind controlled trial of bethanechol and antacid versus placebo and antacid in the treatment of erosive esophagitis. Saco LS, Orlando RC, Levinson SL, Bozymski EM, Jones JD, Frakes JT. Gastroenterology; 1982 Jun 28; 82(6):1369-73. PubMed ID: 7040158 [Abstract] [Full Text] [Related]
18. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial. McCallum RW, Fink SM, Winnan GR, Avella J, Callachan C. Am J Gastroenterol; 1984 Mar 28; 79(3):165-72. PubMed ID: 6367434 [Abstract] [Full Text] [Related]
20. Antacid maintenance therapy in the prevention of duodenal ulcer relapse. Bardhan KD, Hunter JO, Miller JP, Thomson AB, Graham DY, Russell RI, Sontag S, Hines C, Martin T, Gaussen L. Gut; 1988 Dec 28; 29(12):1748-54. PubMed ID: 3065157 [Abstract] [Full Text] [Related] Page: [Next] [New Search]